The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Whatever you do - - do not sell at this price. Hikma right now are one of the best value shares on the stock market. There has been a lot of activity recently with Hikma buying new drugs and forging links with other drug companies. All this has been largely ignored by fund managers but it should at least keep sales buoyant. I am no longer affected by day movement because i feel confident that over time the SP will recover by a significant amount.
On the subject of Just Eat. They are basically a fast food delivery (by scooter) company and have just entered the Ftse100. To make room for them a very long established high tech engineering company (Babcock Power) has been demoted to the Ftse250. It beggars belief.
I'm not an expert on this but from my limited understanding it basically means that Deutsche bank believe the share price will increase. They agree to buy shares at an agreed price and if the SP goes up they have the option to wait until the expiry date and buy the shares at the agreed price or sell the option early because the call option contract has increased in value. I'm sure Mulder will be able to shed more light on it.
Good rise today after a slightly dodgy start. This has more than paid for my ELO concert tickets (£130.00ea). For that price we should have seats on the stage. I get the feeling that the shares have a really strong backing now and hopefully this will continue for some time. Have a good weekend all.
I understand the point you are making but Carillon really was/is a basket case. The company was literally buying contracts for years just to keep the gravy train ticking away with no thought to the long term consequences--Hikma is completely different ie making profits, strong balance sheet etc. We had a statement last week so basically Shorters at this moment in time really don't know much more than we do.
I totally agree with you Mulder. The Shorters will now be seriously evaluating their position on Hikma which will drive the price higher. I know a lot of fund managers will have been at the Healthcare conference in London (Hikma was represented) so i wonder if some positivity is causing the SP to rise. I can't see any other obvious reason for it apart from it's simply starting to go back to where it should be.
Two brokers are now predicting a 30% upturn and yet Shorters are still clinging on here like leeches. . Surely, there must be better prospects elsewhere. Incidentally, not a bad start this morning (up 16p). I hope it stays up.
They are all at the Jefferies Healthcare Conference in London today and tomorrow. Not inconceivable that discussions are going on behind the scenes (300 Healthcare and Pharmaceutical companies in attendance). Time will tell.
They've been talking about it for a while. I think they will get themselves tied in knots with legislation and wish they hadn't bothered. They recently delved into the grocery market and it didn't take them long to discover that there's no money in delivering low margin goods online - - in the last few days they have sneakily introduced a new 3.99 charge for deliveries under! £40.00 l! (was £20.00 previously) and customers pay a two pound tip to the driver by default. If they do go the whole hog i don't know enough about how Hikma operates to give a good answer to your query.
Hikma have announced the purchase of six new drugs for 3 Million. I assume Hikma know what they are doing and that the acquisition should prove profitable. Hardly moved the SP but that's just the way things are at the moment.
Can you please explain why tracker funds would not buy a stock that is now clearly undervalued. This should now be the first choice stock for all tracker funds. Your observation would make perfect sense if the SP was still in the 1400-2000 range.